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questionnaire. METHODS: Data from the Health Survey for England (HSE) of 1996
(n  16,443) and 2006 (n  14,142) were selected in order to assess variation in popula-
tion health status over a 10 year period. Both surveys covered population aged 16 years
and over living in private households. The sample is regularly drawn using a multistage 
stratiﬁ ed random procedure that uses postcode sectors as the primary sample unit. 
Given that only the EQ-5D descriptive system is included to describe self-reported 
health in the HSE, a predicted EQ-5DVAS was estimated for each respondent based
on a regression model developed from data of the 1993 York Measurement and
Valuation of Health Project. RESULTS: Despite being older (2.59 years on average, 
p-value 0.001) and having a slightly higher proportions of women (0.8 percent, p-
value 0.156), the 2006 HSE reﬂ ects that English population has signiﬁ catively (p-value
0.001) reduced its prevalence of self-reported health problems in the last 10 years in 
three out of ﬁ ve EQ-5D dimensions: usual activities, pain/discomfort and anxiety/
depression. Mobility and self-care dimensions, although higher in prevalence, did not
reach statistical signiﬁ cance at 5% level when both years were compared. Health
improvements over time were also reﬂ ected in the utility-weighted EQ-5DINDEX and
predicted EQ-5DVAS (p-value 0.001), having the 16–44 age-group and women the
highest health gains. CONCLUSIONS: EQ-5D is a useful tool for monitoring popula-
tion health. Our ﬁ ndings will assist local policymakers and public health authorities
by improving their knowledge about trends in self-perceived health.
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ASSESSING THE QUALITY OF CONJOINT ANALYSIS APPLICATIONS 
IN HEALTH: A PILOT EVALUATION OF THE ISPOR CHECKLIST FOR
GOOD RESEARCH PRACTICE IN CONJOINT ANALYSIS
Marshall DA1, Hauber AB2, Bridges JF3, Cameron R4, Weaver L2, Dionne J4, Johnson FR2
1University of Calgary, Calgary, AB, Canada, 2RTI Health Solutions, Research Triangle Park, NC, 
USA, 3Johns Hopkins University, Bloomberg School of Public Health, Baltimore, MD, USA, 
4McMaster University, Hamilton, ON, Canada
OBJECTIVES: Increasingly, conjoint analysis , a stated-preference method, is applied
in health outcomes research. Variation in method type and quality make it difﬁ cult to
assess substantive ﬁ ndings. The ISPOR Conjoint Analysis Database Project was estab-
lished to identify and evaluate empirical conjoint analysis applications in the literature 
using the 10-point ISPOR Checklist for Good Research Practice in Conjoint Analysis
(the Checklist). METHODS: Multiple electronic databases published between 1980 
and 2008 were searched to identify conjoint-analysis applications in human health 
studies. Only English-language publications were incorporated. Included studies were
subject to detailed data extraction including descriptive information, methodological
details on survey type, experimental design, survey format, attributes and levels,
sample size, number of conjoint tasks per respondent, and analysis methods. Review 
articles and methods studies were excluded. The detailed extraction form was piloted
to identify key elements to be included in the database using a standardized taxonomy
and to test the Checklist as an evaluative framework for the methodological assessment 
of these studies. RESULTS: The search identiﬁ ed 2,365 citations – 264 met inclusion 
criteria. The number of applied studies increased substantially over time (1980–85 
5 and 2007  42) in a broad range of applications, cancer being the most frequent.
Based on the pilot results, discrete-choice experiments using fractional factorial
designs were most common. Attribute number ranged from 3–6, choice tasks per
respondent ranged from 8–16 and sample size ranged from 30–335. Studies generally
reported less information than required by the 10-point Checklist, especially regarding 
methods used to generate experimental design and reporting design properties. 
CONCLUSIONS: Conjoint analysis in health has expanded to include a broad range 
of applications and methodological approaches. The Checklist provides a framework 
to assess their quality. The conjoint analysis Database project will complete the assess-
ment of the quality and variability of these studies based on the pilot ﬁ ndings.
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THE TRANSLATION AND LINGUISTIC VALIDATION OF THE
NEUROPATHY TOTAL SYMPTOM SCORE-6 SELF-ASSESSED VERSION
(NTSS-6 SA)
Furtado T, Gordon-Stables R, Wild D
Oxford Outcomes Ltd, Oxford, UK
The NTSS-6 SA has been translated into many different languages. It is designed to
assess the severity of peripheral neuropathy symptoms. The objective of this study was
to produce translations that are conceptually equivalent to the original and to other 
language versions, ensuring the relevance of the translations within the target cultures. 
A standard methodology was employed: 2 forward translations, a reconciliation of 
the forward translations, 2 back translations, back translation review; or an in-country 
review; linguistic validation interviews with 5 patients with diabetic peripheral neu-
ropathy in each country, and 2 proofreadings. Numerous cultural and linguistic issues 
became apparent throughout the translation process, including the following: – Many
different pain types are described (e.g. stabbing, shooting, electric-shock like, boring,
aching) which were particularly difﬁ cult as this vocabulary was unavailable in some 
languages. A decision was made to assign the pain types into two groups; ﬁ rstly dull, 
aching pains, and secondly sharper, stabbing pains. These could then be more easily
conveyed and translated. – For many countries, there was no direct translation for
‘pins and needles’. If the country had no idiomatic description of this, ‘feeling as if 
ants crawl on the skin’ was used. – Some items ask about ‘feet’; many of the countries
involved have no speciﬁ c word for ‘feet’, so ‘from ankle to toes’ was translated. – Some
languages were unable to convey ‘asleep feeling’ in a limb; this wording was therefore
converted to ‘numbness’. The NTSS-6 SA has been translated and linguistically vali-
dated using a rigorous translation process. A number of cultural and linguistic issues 
became apparent and were resolved. The measure is now appropriate for use in mul-
tinational trials.
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DEVELOPMENT OF A CHECKLIST TO ASSESS THE QUALITY OF
TRANSLATIONS OF PATIENT-REPORTED OUTCOMES (PRO)
INSTRUMENTS
Conway K1, Acquadro C2
1MAPI Research Trust, Lyon, France, 2Hopital Saint-Louis, Paris, France
OBJECTIVES: Previous research for existing classiﬁ cation systems for translations of 
PRO instruments have shown that existing classiﬁ cations 1) do not give formal evi-
dence of the added value of any one step of the translation process; 2) do not address
the importance of the number of translators or their qualiﬁ cation; and 3) do not give 
formal assurance of the intrinsic quality of the translations. Therefore there is a need 
to develop a comprehensive tool in form of a checklist to assess the quality of the 
translations of PRO instruments. This is the objective of our study. METHODS: We 
conducted 1) interviews with project leaders involved in the translation of PRO instru-
ments; 2) a review of the process used to translate more than 300 instruments in up 
to 130 languages since 1995; and 3) a literature search with the following key words: 
translation, quality, assessment, control and evaluation. RESULTS: Sixteen articles 
were retrieved. The review of these and the interviews conﬁ rmed that 3 key elements
should be assessed at each step of the linguistic validation process, i.e. the method 
used, the team involved and the quality of the end-product. The quality evaluation
should be based on the availability (or not) of evidence backing each step. Mandatory 
evidence required for each step should be provided. For instance, evidence of the 
conceptual deﬁ nition of the different items as deﬁ ned by the developer should be 
provided as well as evidence that translations are conducted within the target coun-
tries. In the pilot test step, evidence of background information and participation of 
subjects should be included. The checklist is currently under development and will be 
presented. CONCLUSIONS: The checklist will provide an increasing level of conﬁ -
dence about the validity of a translation for the context in which the PRO measure
and its translation will be used.
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A NOVEL COMPARISON OF QUALITATIVE DATA SOURCES: 
CONTENT ANALYSIS OF SEMI – STRUCTURED PATIENT
INTERVIEWS VERSUS WEBLOGS (BLOGS)
Acaster SL1, Wild D2
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OBJECTIVES: Blogs have become a fruitful source of qualitative data in recent years
and, as there is a relative lack of qualitative data in many areas of health research, 
this new data source could provide valuable insight in the early stages of research 
development. As such, the objective of this study was to assess the potential use of 
blogs in research development by comparing the data available in blogs with that 
gained from conducting semi-structured interviews with patients. METHODS: The 
subject of menopausal hot ﬂ ashes was used to demonstrate the comparison. Twenty 
semi – structured interviews were conducted with women reporting to suffer hot
ﬂ ashes. The interviews focussed on a description of the symptoms and their impact 
on HRQoL. The themes emerging from the content analysis of these interviews was
then compared to the themes found in twenty blog entries. Four researchers conducted
the analysis, two in each data source group. RESULTS: Both the semi – structured 
interview data and the blog data provided numerous descriptions of the symptoms of 
hot ﬂ ashes, with no discrepancies in thematic content. The interviews did however
allow an explicit discussion of the range in symptom severity and the relationship
between hot ﬂ ashes and night sweats, which could only be inferred in the blog analysis.
Similarly, the effect of hot ﬂ ashes on physical and social functioning, and psychological 
wellbeing, produced similar themes in both data sources. However, while the inter-
views permitted clariﬁ cation of the impact of symptoms on HRQoL, blog analysis 
often relied on inference. CONCLUSIONS: The broad themes elicited from both data
sources were comparable. However, the interactive nature of the interviews produced 
richer, more reliable data than that contained within the blogs. As such the role of 
blog analysis could be that of a cost effective adjunct to literature searches when 
developing research protocols.
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USE OF THE MINI INTERNATIONAL NEUROPSYCHIATRIC
INTERVIEW (M.I.N.I.) – VERSION 6 – IN AN INTERNATIONAL STUDY
Boudrot A1, D’uva F2, Sheehan D3, Lecrubier Y4, Even C4
1Mapi Research Institute, Lyon, France, 2Mapi Research Institute, LYON, France, 3University of 
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The M.I.N.I. is a semi-structured interview designed to explore and diagnose psychiat-
ric disorders in research and clinical settings. Various versions of the US English instru-
ment exist (M.I.N.I. Kid, M.I.N.I. Plus, etc.). Since its development in 1990 some or
all versions of the original have been translated into more than 40 languages. OBJEC-
TIVES: Before using version 6 in 12 countries, it had to be translated according
to a rigorous methodology to meet 3 requirements: (1) concordance with existing 
translations, (2) conceptual equivalence across and (3) linguistic consistency within 
languages. METHODS: The translation process was conducted as follows: forward 
translations on the basis of translations of version 5 produced by psychiatrists appointed 
by the authors, backward translation, clinician review and whenever possible, review 
by the psychiatrists who had coordinated the initial translations. The authors contrib-
uted to the process by identifying the original concepts and reviewing the backward 
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translations. RESULTS: Challenges emerged at two levels. a) At the conceptual level, it 
proved challenging for a linguist to differentiate the distinct but related psychiatric
states investigated by the 16 domains present in the questionnaire. b) At the translation
level, the formulation had to meet the following requirements: i) accurately convey the
concepts and ii) be understandable by the layman. These requirements were all the more
crucial in the context of face-to-face diagnostic interviews where mutual and consistent 
comprehension of terms is essential and may inﬂ uence the overall results. CONCLU-
SIONS: The M.I.N.I. translations were produced to ensure concordance with existing
translations, conceptual equivalence across and linguistic consistency within languages 
to facilitate comparison and pooling of data. This was made possible through the close 
collaboration between linguists and psychiatrists, under the guidance of a coordinating 
centre. The results of the project suggest promoting similar collaboration when trans-
lating other mental health measures in the future.
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THE TRANSLATION AND LINGUISTIC VALIDATION OF THE
SUBJECTIVE WELL-BEING UNDER NEUROLEPTICS – SHORT VERSION 
(SWN-S) QUESTIONNAIRE
Houchin C1, Furtado T1, Wild D1, Naber D2
1Oxford Outcomes Ltd, Oxford, UK, 2University of Hamburg, Hamburg, Germany
OBJECTIVES: The Subjective Well-being Under Neuroleptic – Short version (SWN-S)
has been translated into 30 different languages and is currently being translated into 
further languages. The SWN-S is designed to assess the subjective efﬁ cacy of neuro-
leptic medication. The objective of this study was to produce translations that are 
conceptually equivalent to the original and to other language versions, ensuring the 
relevance of the translations within the target cultures. METHODS: A standard
methodology was employed: two forward translations, a reconciliation of the forward
translations, two back translations, back translation review; or an in-country review;
linguistic validation interviews with ﬁ ve stable patients with schizophrenia in each 
country and two proofreadings. RESULTS: Numerous cultural and linguistic issues
became apparent throughout the translation process, as follows: – The concepts
behind some of the English items were unclear to linguists not specialising in schizo-
phrenia. However, pilot testing revealed that amongst the target population, the
wording was correctly understood. – “I ﬁ nd it easy to draw a line between myself and 
others” was difﬁ cult to translate due to numerous possible connotations of this state-
ment. After consultation with the developer, an accurate connotation was able to be 
conveyed to translators. – “Not in control of myself” did not mean “no self control,” 
contrary to how it had been understood in certain language versions. This was clariﬁ ed 
by the developer. – The item ‘my body feels familiar’ was problematic in some lan-
guages; it was impossible to translate literally in Lithuanian due to linguistic con-
straints, and also problematic in Malay. The closest available wording was determined
and discussed with patients. CONCLUSIONS: The SWN-S has been translated and 
linguistically validated in 30 languages using a rigorous translation process. A number
of cultural and linguistic issues became apparent and were resolved. The measure is
now appropriate for use in multinational trials.
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MULTITRAIT-MULTIMETHOD ANALYSIS OF THREE GENERIC
PREFERENCE-BASED HEALTH-RELATED QUALITY OF LIFE MEASURES
IN THE NATIONAL HEALTH MEASUREMENT STUDY
Maglinte GA1, Hays RD2, Kaplan RM2
1UCLA, Woodland Hills, CA, USA, 2UCLA, Los Angeles, CA, USA
OBJECTIVES: Different generic preference-based health-related quality of life 
(HRQOL) measures may not yield similar quality-adjusted life expectancy, challenging
the meaning of incremental cost-effectiveness ratios in league tables. This study com-
pares corresponding domain scores from different HRQOL measures to evaluate the 
extent to which they tap into the same or unique constructs. METHODS: The SF-36 
(v2), EQ-5D, and HUI-3 were administered to 3844 U.S. adults in the National Health 
Measurement Study, a cross-sectional random-digit dial telephone survey. Mean 
domain and preference-based scores were calculated. Convergent and discriminant 
validity were evaluated by multi-trait multi-method (MTMM) analysis of the three 
HRQOL instruments across the attributes of physical functioning (SF-36 physical 
functioning, HUI-3 ambulation, and EQ-5D mobility), mental health (SF-36 mental 
health, HUI-3 emotion, and EQ-5D anxiety/depression), and pain (SF-36 bodily pain, 
HUI-3 pain, and EQ-5D pain/discomfort). RESULTS: Mean scale scores of the SF-36,
HUI-3, and EQ-5D, respectively, ranged from 47.2 (/10.7) to 53.4 (/10.2) [46.9 
(/11.0) and 53.0 (/10.1) for PCS and MCS], 0.928 (/0.121) to 0.996 (/0.028), 
and 1.0171 (/0.269) to 1.596 (/0.587). Mean preference-based scores obtained
from the SF-36 (calculated from the SF-6D), HUI-3, and EQ-5D were 0.765 (/0.144), 
0.766 (/0.275), and 0.838 (/0.173), respectively (p  0.001 for Bonferroni-
corrected paired t-tests comparing EQ-5D to both SF-36 and HUI-3). The MTMM
matrix had average validity and off-diagonal correlations of 0.622 and 0.404, indicat-
ing high convergent validity. MTMM analysis also showed 91% of convergent validity 
correlations to be signiﬁ cantly larger (p  0.05) than relevant other correlations in the 
MTMM matrix, providing substantial support for discriminant validity. CONCLU-
SIONS: Although the mean preference-based score obtained from the EQ-5D was
different from the SF-36 and HUI-3, MTMM analysis demonstrated good support for 
construct validity among analogous domains of these measures. Further analysis is
required to better understand how similar elements of different generic HRQOL
instruments impact preference-based scores.
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VALUING HEALTH FROM SCRATCH: THE APPLICATION OF
COMMONSENSE PRINCIPLES TO THE DESIGN OF HEALTH STATE 
VALUATION METHODS
Kind P
University of York, York, UK
This paper applies commonsense principles to determine the basis for selecting any 
valuation method. At its centre is the concept that health states compete for location 
within a restricted value space in which full health is assigned the value 1 and dead
the value 0. A descriptive health classiﬁ cation system may generate a large of states 
(972,000 / 18,000 and 245 for HUI3, SF6D and EQ-5D respectively). This argues for
a valuation method that can discriminate between states separated by very small value 
differences. Were all states to have a unique value these differences would be incredibly 
small (1.03E-6, 5.5E-5 & 0.004 respectively). TTO and SG methods used to calibrate
these systems fail a basic credibility test. The numeric output implies a degree of 
measurement performance unlike any other area of human judgement – even those 
with more concrete implications (such as controlling the warmth of our environment)
which are better understood but that report far cruder measurement properties. A 
just-noticeable difference (JND) of 2 degrees Centigrade is reported when testing 
human subjects’ response to temperature. If we assume that human judgement “accu-
rately” discriminates between health states separated by (say) 5 points on a 0–100
VAS scale then we should expect a limited number (n  21) of unique value points. 
Methods that purport to represent health state values with more than this level of 
accuracy imply a human judgement capacity that lacks supportive evidence. A basic
test for any method is whether or not there is evidence that individuals CAN in fact 
discriminate between adjacent health states separated by such small value distances.
Procedures which make minimal assumptions about human judgement are to be pre-
ferred to those with untested performance characteristics. Spurious “accuracy” in 
reported values for health states can be avoided by limiting decrements to a maximum 
of 2 decimal places.
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APPLICATION AND FURTHER VALIDATION OF A PATIENT-REPORTED
OUTCOME INSTRUMENT: PATIENT SATISFACTION WITH
PHARMACEUTICAL CARE QUESTIONNAIRE
Chaudhari PK
Thomas Jefferson University, Philadelphia, PA, USA
OBJECTIVES: Apply and further validate the Patient Satisfaction with Pharmaceutical
Care Questionnaire (PSPCQ) in a different pharmacy practice setting. METHODS:
Five hundred questionnaires were distributed to patients dropping off a prescription
at a high-volume (500 prescriptions/day), 24-hour chain pharmacy, during a 2-week 
period. PSPCQ is a self-administered questionnaire and comprises of 20 Likert-type 
items that measure patient satisfaction with functional and technical dimensions of 
pharmacy services, which are represented by Friendly Explanation (FE) and managing
therapy” (MT) subscales. Patient satisfaction and psychometric properties of 
PSPCQ were evaluated using SPSS. Pearson’s correlation and Student’s t-test were 
used. RESULTS: Survey response rate was 24.2% (n  121). Chronbach’s alpha 
for FE and MT scales were 0.979 and 0.980, respectively. Mean scale scores for 
Global, FE, and MT were 2.88 (SD  1.28), 2.98 (SD  1.27), and 2.74 (SD  1.35), 
respectively. Mean differences in mean scores were 0.24 (P  0.001) between FE and 
MT scales, 0.097 (P  0.001) between Global and FE scales, and 0.15 (P  0.001) 
between Global and MT scales. Inter-scale correlation coefﬁ cients were 0.938
(P  0.001) for FE and MT, 0.988 (P  0.001) for Global and FE, and 0.979
(P  0.001) for Global and MT. “How well the pharmacist answers your questions” 
received second highest rating of 3.21, while “Promptness of prescription drug 
service” received the lowest rating of 2.58, out of the twenty items. CONCLUSIONS:
Signiﬁ cantly higher (P  0.001) overall mean score on MT scale compared to FE scale 
suggests that patients distinguish between activities related to pharmaceutical care 
(MT) and friendly service (FE); and, since usually higher scores are expected from
patients on familiar items, construct validity was demonstrated. Practicing pharma-
cists, in this setting, supported face validity. PSPCQ demonstrated external validity, in 
a high-volume retail pharmacy setting. PSPCQ can be used to assess patient-reported 
quality, in addition to patient awareness, of pharmaceutical care in the community 
pharmacy setting.
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ASSESSING ANXIETY AND DEPRESSION ON AN INTERNATIONAL
LEVEL
Neewoor S1, D’uva F1, Le Halpère A2, Kroenke K3, Engels DJ4
1Mapi Research Institute, LYON, France, 2Sanoﬁ -Aventis, Antony, France, 3Regenstrief Institute
for Health Care, Indianapolis, IN, USA, 4Pﬁ zer, New York, NY, USA
OBJECTIVES: Prior to use in an international study, the Generalized Anxiety Disorder 
Screener (GAD-7) and the Patient Health Questionnaire 9 (PHQ-9) underwent lin-
guistic validation into 67 and 24 languages respectively. A rigorous methodology was
required to ensure conceptual equivalence and cultural relevance between the different 
languages and the original US English instruments. METHODS: The translation
process was conducted by a specialist in each target country, in collaboration with the
developer, using the following standardized methodology: (1) two forward translations 
by professional translators (native speakers of the target language); (2) analysis of the 
translations by the specialist; (3) backward translation by a native English speaker; 
(4) comparison of source and backward version and (5) comprehension test on a
sample of healthy subjects in each target country. Existing translations were integrated
